Biotechnology Industry Market Index
The Biotechnology Industry in the Health Care Sector includes companies primarily engaged in the research, development, manufacturing and/or marketing of products based on genetic analysis and genetic engineering (including companies specializing in protein-based therapeutics to treat human diseases).
The Biotechnology industry index is a market composite index that includes 8 stocks from public trading companies and ADRs with the largest market capitalizations in the Biotechnology industry.
The list of stocks in the Biotechnology industry includes Incyte Corp, Amgen Inc, Vertex Pharmaceuticals Inc, Gilead Sciences Inc, Biogen Inc, Regeneron Pharmaceuticals Inc, AbbVie Inc and Moderna Inc..
9/17/2021 Health Care Sector Biotechnology Industry
$257,505
Change: -0.39%
Open: $257,481
High: $259,718
Low: $251,842
| Incyte Corp (INCY) |
+1.27%
|
| Amgen Inc (AMGN) |
+0.93%
|
| Vertex Pharmaceuticals Inc (VRTX) |
+0.64%
|
| Gilead Sciences Inc (GILD) |
+0.39%
|
| Biogen Inc (BIIB) |
+0.17%
|
| Regeneron Pharmaceuticals Inc (REGN) |
-0.20%
|
| AbbVie Inc (ABBV) |
-0.32%
|
| Biotechnology Industry |
-0.39%
|
| Moderna Inc. (MRNA) |
-2.41%
|
Index Value: $257,505 -0.39%
Volume: 17.62B Average Volume (3 month): 9.98B
Market Capitalization: $211.22T
EBITDA: $26.25T
EPS Basic: $2,161 Diluted: $2,161 Actual: $5,047
EPS Estimation: High $5,188 Medium: $4,517 Low: $3,636
EPS TTM: $9,290
P/E: 28.70
PEG Ratio (5 year Expected): 2.24
Dividend Yield: 2.14%
Dividend Rate: $5,527
Dividend Yield (Forward): 2.21%
Dividend Rate (Forward): $5,686
Shares Outstanding: 1.81T
Book Value: $29,096
Short Ratio: 2.48
Price Target (1 year): $275,045
Volume: 17.62B Average Volume (3 month): 9.98B
Market Capitalization: $211.22T
EBITDA: $26.25T
EPS Basic: $2,161 Diluted: $2,161 Actual: $5,047
EPS Estimation: High $5,188 Medium: $4,517 Low: $3,636
EPS TTM: $9,290
P/E: 28.70
PEG Ratio (5 year Expected): 2.24
Dividend Yield: 2.14%
Dividend Rate: $5,527
Dividend Yield (Forward): 2.21%
Dividend Rate (Forward): $5,686
Shares Outstanding: 1.81T
Book Value: $29,096
Short Ratio: 2.48
Price Target (1 year): $275,045
| Symbol | Security | Price | Gain | Volume | vol. Str. | Weight |
| INCY | Incyte Corp | 75.99 | +1.27% | 2.22M | 1.89 | 2.21% |
| AMGN | Amgen Inc | 219.38 | +0.93% | 5.64M | 2.36 | 16.43% |
| VRTX | Vertex Pharmaceuticals Inc | 188.30 | +0.64% | 1.96M | 0.95 | 6.44% |
| GILD | Gilead Sciences Inc | 71.61 | +0.39% | 10.89M | 1.79 | 11.84% |
| BIIB | Biogen Inc | 300.19 | +0.17% | 1.50M | 1.18 | 5.90% |
| REGN | Regeneron Pharmaceuticals Inc | 651.88 | -0.20% | 690,759 | 0.88 | 9.19% |
| ABBV | AbbVie Inc | 107.73 | -0.32% | 12.18M | 1.77 | 25.10% |
| Biotechnology Industry | 257,505.39 | -0.39% | 17.62B | 1.77 | 11.22% | |
| MRNA | Moderna Inc. | 430.05 | -2.41% | 30.30M | 1.70 | 22.89% |
| Symbol | Security | Market Cap | EPS TTM | P/E | Div Yield | PEG Ratio |
| INCY | Incyte Corp | 16.571B | $1.52 | 49.78 | 1.21 | |
| AMGN | Amgen Inc | 123.428B | $9.83 | 23.52 | 3.08% | 2.31 |
| VRTX | Vertex Pharmaceuticals Inc | 48.539B | $7.58 | 26.18 | 1.65 | |
| GILD | Gilead Sciences Inc | 89.434B | $4.10 | 17.81 | 3.87% | 7.82 |
| BIIB | Biogen Inc | 44.664B | $12.46 | 28.07 | -2.24 | |
| REGN | Regeneron Pharmaceuticals Inc | 69.861B | $55.69 | 11.63 | 3.06 | |
| ABBV | AbbVie Inc | 191.103B | $3.71 | 32.25 | 4.71% | 1.90 |
| Biotechnology Industry | $211.22T | $9,290 | 28.70 | 2.14% | 2.24 | |
| MRNA | Moderna Inc. | 177.867B | N/A | N/A | 0.80 | |
Back to Market Summary